Effects of Probiotic Against Respiratory & Gastrointestinal Illnesses in Children
Respiratory Tract Infections
About this trial
This is an interventional treatment trial for Respiratory Tract Infections focused on measuring probiotic, respiratory tract infections, Bifidobacterium, children
Eligibility Criteria
Inclusion Criteria: preschool children (<7 years old), and having respiratory and/or gastrointestinal diseases symptoms. Willing to commit throughout the experiment Exclusion Criteria: Long term medication due to certain severe illness (6 months or more) Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Sites / Locations
- Department of Paediatrics, Kulliyyah of Medicine, IIUM Medical Centre, International Islamic University MalaysiaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Probiotic
Placebo
Intervention consists of daily administration of excipient plus Bifidobacterium lactis subsp. infantis B8762 at 0.5x10 log colony forming unit (CFU)/day administered daily for 4-weeks
Intervention consists of daily administration of 2g/sachet of excipient administered daily for 4-weeks